4-40944945-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004307.2(APBB2):c.964G>A(p.Val322Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004307.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBB2 | NM_004307.2 | c.964G>A | p.Val322Ile | missense_variant | 7/18 | ENST00000508593.6 | NP_004298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APBB2 | ENST00000508593.6 | c.964G>A | p.Val322Ile | missense_variant | 7/18 | 1 | NM_004307.2 | ENSP00000427211.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152048Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249574Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135404
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461708Hom.: 0 Cov.: 33 AF XY: 0.0000344 AC XY: 25AN XY: 727160
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152166Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.964G>A (p.V322I) alteration is located in exon 7 (coding exon 3) of the APBB2 gene. This alteration results from a G to A substitution at nucleotide position 964, causing the valine (V) at amino acid position 322 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at